Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halder, S. K.
Right arrow Articles by Datta, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halder, S. K.
Right arrow Articles by Datta, P. K.
[Cancer Research 66, 6156-6166, June 15, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Oncogenic Function of a Novel WD-Domain Protein, STRAP, in Human Carcinogenesis

Sunil K. Halder1, Govindaraj Anumanthan1, Ramakoti Maddula1, Jason Mann3, Anna Chytil2, Adriana L. Gonzalez4, M. Key Washington4, Harold L. Moses2, R. Daniel Beauchamp1,2 and Pran K. Datta1,2

Departments of 1 Surgery and 2 Cancer Biology, Vanderbilt-Ingram Cancer Center; and Departments of 3 Medicine and 4 Medical Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee

Requests for reprints: Pran K. Datta, Surgical Oncology Division, Department of Surgery, Vanderbilt University School of Medicine, 1161 21st Avenue South, A-3310C MCN, Nashville, TN 37232. Phone: 615-343-1280; Fax: 615-343-1355; E-mail: pran.datta{at}vanderbilt.edu.

The development and progression of malignancies is a complex multistage process that involves the contribution of a number of genes giving growth advantage to cells when transformed. The role of transforming growth factor-ß (TGF-ß) in carcinogenesis is complex with tumor-suppressor or prooncogenic activities depending on the cell type and the stage of the disease. We have previously reported the identification of a novel WD-domain protein, STRAP, that associates with both TGF-ß receptors and that synergizes with the inhibitory Smad, Smad7, in the negative regulation of TGF-ß–induced transcription. Here, we show that STRAP is ubiquitously expressed and is localized in both cytoplasm and nucleus. STRAP is up-regulated in 60% colon and in 78% lung carcinomas. Stable expression of STRAP results in activation of mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and in down-regulation of the cyclin-dependent kinase inhibitor p21Cip1, which results in retinoblastoma protein hyperphosphorylation. In addition, we have observed that Smad2/3 phosphorylation, TGF-ß–mediated transcription, and growth inhibition are induced in STRAP-knockout mouse embryonic fibroblasts compared with wild-type cells. Ectopic expression of STRAP in A549 lung adenocarcinoma cell line inhibits TGF-ß–induced growth inhibition and enhances anchorage-independent growth of these cells. Moreover, overexpression of STRAP increases tumorigenicity in athymic nude mice. Knockdown of endogenous STRAP by small interfering RNA increases TGF-ß signaling, reduces ERK activity, increases p21Cip1 expression, and decreases tumorigenicity. Taken together, these results suggest that up-regulation of STRAP in human cancers may provide growth advantage to tumor cells via TGF-ß–dependent and TGF-ß–independent mechanisms, thus demonstrating the oncogenic function of STRAP. (Cancer Res 2006; 66(12): 6156-66)




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Jung, H.-A. Seong, and H. Ha
NM23-H1 Tumor Suppressor and Its Interacting Partner STRAP Activate p53 Function
J. Biol. Chem., November 30, 2007; 282(48): 35293 - 35307.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Cao, K. Yu, C. Banh, V. Nguyen, A. Ritz, B. J. Raphael, Y. Kawakami, T. Kawakami, and A. R. Salomon
Quantitative Time-Resolved Phosphoproteomic Analysis of Mast Cell Signaling
J. Immunol., November 1, 2007; 179(9): 5864 - 5876.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Chiosea, E. Jelezcova, U. Chandran, J. Luo, G. Mantha, R. W. Sobol, and S. Dacic
Overexpression of Dicer in Precursor Lesions of Lung Adenocarcinoma
Cancer Res., March 1, 2007; 67(5): 2345 - 2350.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Anumanthan, S. K. Halder, D. B. Friedman, and P. K. Datta
Oncogenic Serine-Threonine Kinase Receptor-Associated Protein Modulates the Function of Ewing Sarcoma Protein through a Novel Mechanism.
Cancer Res., November 15, 2006; 66(22): 10824 - 10832.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.